Exelixis, Inc. (EXEL)
NASDAQ: EXEL · Real-Time Price · USD
69.39
+3.19 (4.82%)
At close: Oct 30, 2026, 4:00 PM EDT
70.36
+0.97 (1.40%)
After-hours: Oct 30, 2026, 7:51 PM EDT
Exelixis Market Cap
Exelixis has a market cap or net worth of $16.93 billion as of October 30, 2026. It is the 1,366th most valuable company in the world and the 538th biggest in the United States. Its market cap has increased by 59.51% in one year.
Market Cap
16.93B
Enterprise Value
15.69B
1-Year Change
59.51%
Global Rank
Country Rank
#538 United States
Category
ChartMarket Cap Chart
Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $16.93B, an increase of 2,584.20%. That is a compound annual growth rate of 13.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 16.93B | 44.08% |
| Dec 31, 2025 | 11.75B | 23.57% |
| Dec 31, 2024 | 9.51B | 27.47% |
| Dec 29, 2023 | 7.46B | 44.19% |
| Dec 30, 2022 | 5.17B | -10.54% |
| Dec 31, 2021 | 5.78B | -7.11% |
| Dec 31, 2020 | 6.23B | 16.30% |
| Dec 31, 2019 | 5.35B | -8.96% |
| Dec 31, 2018 | 5.88B | -34.61% |
| Dec 29, 2017 | 8.99B | 110.58% |
| Dec 30, 2016 | 4.27B | 233.29% |
| Dec 31, 2015 | 1.28B | 355.89% |
| Dec 31, 2014 | 281.10M | -75.11% |
| Dec 31, 2013 | 1.13B | 34.59% |
| Dec 31, 2012 | 839.00M | 36.62% |
| Dec 30, 2011 | 614.10M | -31.37% |
| Dec 31, 2010 | 894.80M | 13.07% |
| Dec 31, 2009 | 791.40M | 49.29% |
| Dec 31, 2008 | 530.10M | -41.23% |
| Dec 31, 2007 | 902.00M | 4.64% |
| Dec 29, 2006 | 862.00M | 10.08% |
| Dec 30, 2005 | 783.10M | 10.19% |
| Dec 31, 2004 | 710.70M | 41.83% |
| Dec 31, 2003 | 501.10M | 9.05% |
| Dec 31, 2002 | 459.50M | -44.16% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Insmed | 24.70B |
| Incyte | 24.54B |
| BioNTech SE | 22.15B |
| Alnylam Pharmaceuticals | 22.10B |
| Ascendis Pharma | 16.50B |
| Halozyme Therapeutics | 14.86B |
| BridgeBio Pharma | 14.60B |
| Jazz Pharmaceuticals | 14.02B |